Search

everythinglearnresearchcommunity

for

Search:↓

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

New treatments focusing on immune pathways show promise for stubborn hair loss.

The document concludes that significant investment in agricultural innovation is necessary to achieve global food security and nutrition.

RSPO1 mutations in certain patients lead to skin cells that don't develop properly and are more likely to become invasive, increasing the risk of skin cancer.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

Damaged hair follicles make mice more prone to skin inflammation and skin cancer after UV exposure.

Hair relaxers are linked to reduced cystine levels and potential hair damage.

Higher levels of MiR-92a-1-5p and miR-328-3p found in female hair loss patients.

People with alopecia areata often have lower iron levels than healthy people.

Researchers created human hair follicles using a new method that could help treat hair loss.

The 308-nm Excimer laser is effective and safe for treating patchy alopecia areata in children.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

Fractional laser treatment helped hair regrowth in patients with alopecia areata.

Exosomes show promise for future tissue regeneration.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Men with hair loss experience lower quality of life, worsened by factors like age, severity, and treatment history.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

The document concludes that while "hair follicle cloning" shows promise for unlimited donor hair, it faces challenges with consistency and safety in humans.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

Post-finasteride syndrome causes sexual, physical, and psychological symptoms, but more research is needed to understand its causes and connection to finasteride.

Using a nonablative fractional laser with topical minoxidil can effectively and safely promote hair regrowth in alopecia areata patients.

Cronkhite-Canada syndrome can be diagnosed without gastrointestinal polyps if there is severe mucosal atrophy and edema.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Taking finasteride daily can effectively and safely increase hair density and thickness for women with hair loss.

Men with early hair loss may have higher insulin resistance and should be checked for related health issues.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Genomic approach finds new possible treatments for hair loss.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.